Archived Facts

(Reuters) – A prostate cancer drug developed by Medivation Inc and Astellas Pharma Inc has been approved by the U.S. Food and Drug Administration for use in men whose cancer has spread despite treatment with hormone therapy and chemotherapy, the agency said on Friday.

Popular Posts:

Related Posts:

Leave a Reply